midodrine has been researched along with Priapism in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Priapism: A prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated midodrine as oral treatment for pharmacologically induced priapism in spinal cord injured patients." | 7.75 | Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients. ( Mieusset, R; Plante, P; Previnaire, JG; Soler, JM, 2009) |
| "We evaluated midodrine as oral treatment for pharmacologically induced priapism in spinal cord injured patients." | 3.75 | Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients. ( Mieusset, R; Plante, P; Previnaire, JG; Soler, JM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soler, JM | 1 |
| Previnaire, JG | 1 |
| Mieusset, R | 1 |
| Plante, P | 1 |
1 other study available for midodrine and Priapism
| Article | Year |
|---|---|
Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adult; Alprostadil; Erectile Dysfunction; Humans; I | 2009 |